Showing results (71-80 of 87) with videos related to
Sort By:
Pageof 9
Annals of Internal Medicine|May 1, 1982
Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patientsJ U Gutterman, S Fine, J Quesada, et al.Bioorganic & Medicinal Chemistry Letters|February 15, 2012
Discovery of vinylcycloalkyl-substituted benzimidazole TRPM8 antagonists effective in the treatment of cold allodyniaRaul R Calvo, Sanath K Meegalla, Daniel J Parks, et al.Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Parallel methods for the preparation and SAR exploration of N-ethyl-4-[(8-alkyl-8-aza-bicyclo[3.2.1]oct-3-ylidene)-aryl-methyl]-benzamides, powerful mu and delta opioid agonistsSteven J Coats, Mark J Schulz, John R Carson, et al.Nature|August 23, 2023
Proton transport through nanoscale corrugations in two-dimensional crystalsO J Wahab, E Daviddi, B Xin, et al.Human Pathology|March 24, 1999
Interobserver reproducibility of the Lagios nuclear grading system for ductal carcinoma in situN Sneige, M D Lagios, R Schwarting, et al.Pharmacology, Biochemistry, and Behavior|May 5, 2010
Ex vivo delta opioid receptor autoradiography: CNS receptor occupancy of two novel compounds over their antihyperalgesic dose rangeEllen E Codd, Jianya Ma, Sui-Po Zhang, et al.Bioorganic & Medicinal Chemistry Letters|May 22, 2012
A novel series of pyrazolylpiperidine N-type calcium channel blockersNalin L Subasinghe, Mark J Wall, Michael P Winters, et al.Bioorganic & Medicinal Chemistry Letters|October 20, 2018
Discovery and optimization of a novel series of pyrazolyltetrahydropyran N-type calcium channel (Cav 2.2) blockers for the treatment of painMark J Wall, Nalin L Subasinghe, Michael P Winters, et al.Bioorganic & Medicinal Chemistry Letters|March 25, 2008
N-pyridin-3-yl- and N-quinolin-3-yl-benzamides: modulators of human vanilloid receptor 1 (TRPV1)Michele C Jetter, James J McNally, Mark A Youngman, et al.Bioorganic & Medicinal Chemistry Letters|March 17, 2012
The design and synthesis of novel, phosphonate-containing transient receptor potential melastatin 8 (TRPM8) antagonistsJay M Matthews, Ning Qin, Raymond W Colburn, et al.Pageof 9